OpenAI 2026 hackathon

Another Stupid Monday

A self-care app designed to reduce overwhelm by focusing on one doable thing at a time.

Solo project by Halim Jarrar · 1 likes · 0 comments

Archive position — measured, not model output

1 like on Devpost

506 of the 7,856 archived projects have more likes, and 1,758 share exactly 1 — so this project's #605 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

Another Stupid Monday (ASM) is a self-care app designed to reduce overwhelm by focusing on one doable task at a time. It introduces a new self-care activity each week, starting on Mondays, and allows users to complete tasks at their own pace without penalty.

What changed

The project was built during an OpenAI hackathon (Devpost submission), using AI tools like Codex and Hermes for development. The author, Halim Jarrar, a psychotherapist with no prior coding experience, developed the app from scratch using AI-assisted software development methods.

Single most important open question

Is there evidence of user adoption or engagement beyond the developer's own use and testing?

Note: This analysis is based entirely on the self-reported, unverified account provided by the author. No external data, revenue figures, customer base, or traction metrics are available.

Back to contents

What The Product Actually Is

The description states that ASM is a self-care app that introduces one task per week, beginning every Monday. Most tasks are completed once, while others encourage repetition during the week. Users can revisit previous tasks if they don’t finish them in time, and there is no penalty or pressure.

  • Product function: Delivers one manageable self-care activity weekly.
  • User interaction model: Tasks are available for completion over time; no deadline enforcement.
  • Core idea: Reduce overwhelm through simplicity and repetition.
  • Not evidenced: Specific features beyond task delivery, UI design, or in-app shop details.

The author describes the app as having 100 tasks designed to be completed slowly over time. However, no further detail is given on how these tasks are structured or whether they vary by type (e.g., mindfulness, journaling).

Back to contents

Positioning & Claim Evolution

The author positions ASM as a mental-health support tool that avoids the complexity of other apps by focusing on one task at a time.

  • Key claim: Mental-health apps often overwhelm users; this app simplifies the experience.
  • Evolution of positioning: From a personal solution (a psychotherapist’s insight) to a scalable product built with AI tools.
  • Not evidenced: Market positioning strategy, target segment definition, or differentiation from existing mental health apps.

The author emphasizes accessibility and multilingual support as key goals. However, no evidence is provided about how this has been implemented or tested in practice.

Back to contents

Target Customer & ICP

The description implies that the intended users are individuals seeking mental wellness support who may be overwhelmed by more feature-rich apps.

  • Target customer profile: People looking for low-effort, consistent self-care practices.
  • ICP inferred: Individuals interested in mental health and well-being, especially those sensitive to app complexity or overwhelm.
  • Not evidenced: Specific demographics, user personas, or actual customer data.

The author notes that the app supports more than 65 languages, suggesting a global audience. However, no information is given on which markets are prioritized or how users are recruited.

Back to contents

Business Model & Pricing Evidence

There is an in-app shop mentioned, but no details are provided about pricing, monetization strategy, or revenue streams.

  • Monetization model: In-app purchases exist, though not described in detail.
  • Not evidenced: Revenue model, pricing tiers, or sales figures.
  • Inference: If the app is free to download with optional purchases, it likely follows a freemium model.

The description does not clarify whether the app is free-to-use or paid, nor how the in-app shop integrates into the overall user experience.

Back to contents

Technical & Delivery Signals

The author built the app using AI tools such as Codex and Hermes, along with Flutter for cross-platform development.

  • Development stack: Android (Flutter), iOS, Cloudflare, Telegram, OpenAI Codex, Hermes Agent.
  • Tooling approach: AI-assisted development without traditional programming background.
  • Delivery method: App available on Apple App Store; next step is Google Play release.
  • Not evidenced: Technical architecture, scalability plans, or performance metrics.

The author reports using local and remote debugging methods via Telegram and Cloudflare. However, no information is given about backend infrastructure, data handling, or security practices.

Back to contents

Traction & Maturity Signals

No evidence of user traction, engagement, or adoption beyond the developer’s own use and testing.

  • Not evidenced: User base, download numbers, retention rates, or usage analytics.
  • Inference: The app is likely in early-stage development, based on its hackathon origin and limited public presence.
  • Not evident: Any form of beta testing, feedback loops, or product iteration history.

The author mentions improvements made during Build Week but provides no data to support growth or user satisfaction.

Back to contents

Competitive Context

The description does not reference competitors or market positioning relative to existing mental health apps.

  • Not evidenced: Competitor landscape, direct or indirect substitutes.
  • Inference: Given the focus on simplicity and task-based self-care, ASM may compete with apps like Headspace, Calm, or Moodnotes, but no such comparison is made.

The author does not discuss how ASM differs from or aligns with other mental health tools in the market.

Back to contents

Key Risks & Red Flags

Several potential issues arise from the lack of verified data and unproven assumptions:

  • Risk: Lack of user feedback or validation.
  • Red flag: No evidence of monetization strategy or revenue generation.
  • Risk: Reliance on AI tools for development raises concerns about long-term maintainability and scalability.
  • Red flag: No mention of privacy, compliance (e.g., HIPAA), or clinical validation.

The app’s reliance on AI-generated code without a clear path to human oversight or maintenance could pose risks in terms of quality control and future development.

Back to contents

Diligence Questions To Ask The Founders

  1. What is the actual user engagement rate? How many people are using the app?
  2. Are there any clinical studies or expert validations supporting the effectiveness of the tasks?
  3. How does the in-app shop integrate into the overall user experience, and what are its conversion rates?
  4. What are the long-term plans for localization beyond 65 languages?
  5. Has the developer considered legal or regulatory compliance (e.g., healthcare data protection)?
  6. What is the roadmap for monetization beyond optional purchases?

These questions aim to uncover whether the app has moved beyond concept stage and into measurable traction or adoption.

Back to contents

Investment/Partnership Verdict

Not evidenced: No financials, revenue, or customer data exist to support an investment or partnership decision.

  • Confidence level: Low — based on self-reported narrative only.
  • Inference: The project appears to be a proof-of-concept with strong conceptual clarity but lacks demonstrated traction or scalability.
  • Verdict: Not suitable for investment or partnership at this stage without further evidence of user engagement, monetization, or market validation.

This is an early-stage idea with potential for growth if validated through real-world usage and clinical integration. However, current evidence does not support a commercial due-diligence read beyond the initial concept.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.